Cas:4028-98-2 1-[10-(4-amino-2-methylquinolin-1-ium-1-yl)decyl]-2-methylquinolin-1-ium-4-amine,diacetate manufacturer & supplier

Chemical Name:1-[10-(4-amino-2-methylquinolin-1-ium-1-yl)decyl]-2-methylquinolin-1-ium-4-amine,diacetate

CAS.NO:4028-98-2

Synonyms:1,1′-Decamethylenebis(4-aminoquinaldinium acetate);DEQUALINIUM ACETATE;Quinolinium,1,1′-(1,10-decanediyl)bis(4-amino-2-methyl-,diacetate;1,1′-(1,10-Decanediyl)bis(4-amino-2-methylquinolinium) diacetate;Dequadin acetate;Decalinium acetate;EINECS 223-712-5;1,1′-(Decane-1,10-diyl)bis(4-amino-2-methylquinolinium) diacetate;Quinaldinium,1,1′-decamethylenebis(4-amino-,diacetate

Molecular Formula:C₃₄H₄₆N₄O₄

Molecular Weight:574.75300

HS Code:2933499090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:132.16000

Exact Mass:574.35200

LogP:7.37400

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,1′-Decamethylenebis(4-aminoquinaldinium acetate) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Quinaldinium,1,1′-decamethylenebis(4-amino-,diacetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,1′-Decamethylenebis(4-aminoquinaldinium acetate) Use and application,1,1′-Decamethylenebis(4-aminoquinaldinium acetate) technical grade,usp/ep/jp grade.

Related News: The little-known Italian company making the glass vials for most of the globe’s Covid-19 vaccines just scored a rare feat: a New York Stock Exchange IPO. It’s the biggest public offering for an Italian firm in the U.S. since Ferrari’s 2015 listing. 3-Hydroxymethyl-2-(3-methoxy-propyl)-1,1-dioxo-1,2-dihydro-1λ6-thieno[3,2-e][1,2]thiazine-6-sulfonic acid amide manufacturers The group, after examining Soliris’ late-stage trial data, determined they’re highly certain it produces a small benefit to patients who are positive for anti-AChR antibodies, while there’s a “moderate certainty of a small or substantial net health benefit.” 5-[6-(N-cyclohexyl-N-benzylaminocarbonyl)hexyloxy]-3,4-dihydrocarbostyril suppliers TULIP-2 demonstrated superiority across multiple efficacy endpoints versus placebo with both arms receiving standard therapy. 1H-Benzimidazole, 2-(3-cyclohexen-1-yl)-6-fluoro-1-(4-fluorophenyl)- vendor & factory.